Emgality demonstrated a consistent safety profile across five Phase 3 studies in migraine and episodic cluster headache (N=3262)1-7
Lilly continues to monitor the safety data of Emgality in the general population.
Download savings cards to help eligible patients on Emgalitya
aGovernmental beneficiaries excluded; terms and conditions apply.
References: 1. Emgality [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. 2. Stauffer VL, Dodick DW, Zhang Q, et al. Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial. JAMA Neurol. 2018:75(9):1080-1088. 3. Skljarevski V, Matharu M, Millen BA, et al. Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. Cephalalgia. 2018;38(8):1442-1454. 4. Detke HC, Goadsby PJ, Wang S, et al. Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology. 2018;91(24):e2211-e2221. 5. Data on File. Lilly USA, LLC. DOF-GZ-US-0107. 6. Camporeale A, Kudrow D, Sides R, et al. A phase 3, long-term, open-label safety study of galcanezumab in patients with migraine. BMC Neurol. 2018;18(1):188. doi:10.1186/s12883-018-1193-2. 7. Bangs ME, Kudrow D, Wang S, et al. Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies. BMC Neurol. 2020;20:90. doi:10.1186/s12883-020-1609-7. 8. Data on File. Lilly USA, LLC. DOF-GZ-US-0008. 9. Data on File. Lilly USA, LLC. DOF-GZ-US-0007. 10. Data on File. Lilly USA, LLC. DOF-GZ-US-0026. 11. Oakes TM, Kovacs R, Rosen N, et al. Evaluation of cardiovascular outcomes in adult patients with episodic or chronic migraine treated with galcanezumab: data from three phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies. Headache. 2020;60:110-123. 12. Data on File. Lilly USA, LLC. DOF-GZ-US-0165. 13. Data on File. Lilly USA, LLC. DOF-GZ-US-0137. 14. Data on File. Lilly USA, LLC. DOF-GZ-US-0139. 15. Data on File. Lilly USA, LLC. DOF-GZ-US-0140.